{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:04:21Z","timestamp":1776427461294,"version":"3.51.2"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.bpa.2003.12.005","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T10:10:05Z","timestamp":1085825405000},"page":"455-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["The systemic inflammatory response syndrome"],"prefix":"10.1016","volume":"18","author":[{"given":"Markus A","family":"Weigand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert J","family":"Bardenheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Bouchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2003.12.005_BIB1","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/00003246-200107001-00035","article-title":"Epidemiology of sepsis: an update","volume":"29","author":"Angus","year":"2001","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [comment]","volume":"29","author":"Angus","year":"2001","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB4","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.bpa.2003.12.005_BIB5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.CCM.0000063088.86079.03","article-title":"Heat shock protein 70\u22122+1267 AA homozygotes have an increased risk of septic shock in adults with community-acquired pneumonia","volume":"31","author":"Waterer","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB7","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1097\/00003246-200008000-00075","article-title":"Gene in a haystack: tumor necrosis factor polymorphisms and outcome in sepsis","volume":"28","author":"Freeman","year":"2000","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB8","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1007\/s001340051125","article-title":"Cytokine and cytokine receptor polymorphisms in infectious disease","volume":"26","author":"van Deventer","year":"2000","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.bpa.2003.12.005_BIB10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/00003246-199908000-00039","article-title":"Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? [comment]","volume":"27","author":"Opal","year":"1999","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","article-title":"Phylogenetic perspectives in innate immunity","volume":"284","author":"Hoffmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.12.005_BIB12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB13","first-page":"445","article-title":"TREMs in the immune system and beyond. Nature reviews","volume":"3","author":"Colonna","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0952-7915(98)80029-0","article-title":"Antimicrobial peptides of vertebrates","volume":"10","author":"Ganz","year":"1998","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice mutations in TLR4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.12.005_BIB18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA [comment]","volume":"408","author":"Hemmi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/416194a","article-title":"RICK\/Rip2\/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems","volume":"416","author":"Kobayashi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni0901-835","article-title":"TIRAP: an adapter molecule in the Toll signaling pathway [comment]","volume":"2","author":"Horng","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bpa.2003.12.005_BIB24","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1128\/IAI.69.12.7172-7276.2001","article-title":"Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis","volume":"69","author":"Echtenacher","year":"2001","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.bpa.2003.12.005_BIB25","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.4049\/jimmunol.169.6.2823","article-title":"Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection","volume":"169","author":"Weighardt","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1074-7613(03)00177-8","article-title":"Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments","volume":"19","author":"Elzey","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.bpa.2003.12.005_BIB28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1084\/jem.193.6.679","article-title":"Pivotal role of signal transducer and activator transcription (stat)2 and stat6 in the innate immune response during sepsis","volume":"193","author":"Matsukawa","year":"2001","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(03)00171-7","article-title":"TNF\/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection","volume":"19","author":"Serbina","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.bpa.2003.12.005_BIB32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.3895437","article-title":"Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin","volume":"229","author":"Beutler","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.12.005_BIB33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.12.005_BIB34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/348550a0","article-title":"Interleukin-1 receptor antagonist reduces mortality from endotoxin shock","volume":"348","author":"Ohlsson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/72262","article-title":"Protection from septic shock by neutralization of macrophage migration inhibitory factor","volume":"6","author":"Calandra","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB36","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1164\/ajrccm.160.supplement_1.4","article-title":"Granulocyte apoptosis and its role in the resolution and control of lung inflammation","volume":"160","author":"Haslett","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB37","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.12.005_BIB38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1074-7613(03)00092-X","article-title":"Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation","volume":"18","author":"Legler","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.bpa.2003.12.005_BIB39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1286-4579(00)00396-8","article-title":"The role of the interleukin-1\/Toll-like receptor superfamily in inflammation and host defence","volume":"2","author":"Fitzgerald","year":"2000","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.bpa.2003.12.005_BIB40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevImmunol.v15.i1.30","article-title":"Interleukin-1 receptor antagonist","volume":"15","author":"Lennard","year":"1995","journal-title":"Critical Reviews in Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB41","first-page":"483","article-title":"Interleukin-18, a proinflammatory cytokine","volume":"11","author":"Dinarello","year":"2000","journal-title":"European Cytokine Network"},{"key":"10.1016\/j.bpa.2003.12.005_BIB42","first-page":"511","article-title":"Leukocyte endothelial interactions\u2014a double edged sword","volume":"41","author":"Bardenheuer","year":"1999","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.bpa.2003.12.005_BIB43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.194.2.219","article-title":"The use of lymphocyte function-associated antigen (LFA)-1 deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils","volume":"194","author":"Henderson","year":"2001","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/86539","article-title":"Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients","volume":"7","author":"Ibbotson","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB45","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.4049\/jimmunol.166.12.7362","article-title":"The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with streptococcus pneumoniae","volume":"166","author":"Prince","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature01300","article-title":"Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis","volume":"421","author":"Mamdouh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm832","article-title":"Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors","volume":"9","author":"Fan","year":"2003","journal-title":"Nature Medecine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.SLA.0000055274.56407.71","article-title":"Regional and systemic cytokine responses to acute inflammation of the vermiform appendix","volume":"237","author":"Rivera-Chavez","year":"2003","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.bpa.2003.12.005_BIB49","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1182\/blood.V90.9.3356","article-title":"Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis","volume":"90","author":"Keel","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bpa.2003.12.005_BIB50","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.167.7.3919","article-title":"Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis","volume":"167","author":"Emmanuilidis","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB52","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1749-6632.2000.tb05432.x","article-title":"Macrophage migration inhibitory factor (MIF). A critical neurohumoral mediator","volume":"917","author":"Petrovsky","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bpa.2003.12.005_BIB53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1067\/msy.2000.104118","article-title":"Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production","volume":"127","author":"Weighardt","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.bpa.2003.12.005_BIB57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1164\/ajrccm.163.2.2007102","article-title":"Normal responses to injury prevent systemic inflammation and can be immunosuppressive","volume":"163","author":"Munford","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(05)60606-X","article-title":"Anti-inflammatory cytokine profile and mortality in febrile patients","volume":"351","author":"van Dissel","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2003.12.005_BIB59","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.161.5.2655","article-title":"Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production","volume":"161","author":"Hensler","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB60","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"Doecke","year":"1997","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.CCM.0000048629.32625.5D","article-title":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis [comment]","volume":"31","author":"Root","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00134-003-1666-6","article-title":"Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis","volume":"29","author":"Nierhaus","year":"2003","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB64","first-page":"886","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.bpa.2003.12.005_BIB65","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc1860","article-title":"Reducing mortality in sepsis: new directions","volume":"6","author":"Vincent","year":"2002","journal-title":"Critical Care (London)"},{"key":"10.1016\/j.bpa.2003.12.005_BIB66","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.282.1.54","article-title":"Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial [comment]","volume":"282","author":"Ranieri","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.bpa.2003.12.005_BIB68","first-page":"23","article-title":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome","volume":"289","author":"Imai","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.bpa.2003.12.005_BIB69","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1164\/rccm.200206-611CP","article-title":"On the physiologic and clinical relevance of lung-borne cytokines during ventilator-induced lung injury","volume":"167","author":"Dreyfuss","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB70","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control [comment]","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB72","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00134-002-1629-3","article-title":"Hyperglycemia and oxidative stress: complex relationships with attractive prospects","volume":"29","author":"Leverve","year":"2003","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1016\/j.bpa.2003.12.005_BIB74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunology and Medical Microbiology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochimica Biophysica Acta"},{"key":"10.1016\/j.bpa.2003.12.005_BIB76","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2002-021478","article-title":"Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels","volume":"88","author":"Hansen","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpa.2003.12.005_BIB77","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.CIR.0000012529.00367.0F","article-title":"Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation","volume":"105","author":"Gao","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2003.12.005_BIB78","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s001340000790","article-title":"The endothelial response to oxygen deprivation: biology and clinical implications","volume":"27","author":"Karimova","year":"2001","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB80","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bpa.2003.12.005_BIB81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"The release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","article-title":"Heat shock proteins as regulators of the immune response","volume":"362","author":"Pockley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2003.12.005_BIB83","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and hemodynamic effects of \u2018low-dose\u2019 hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study","volume":"167","author":"Keh","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/cc1825","article-title":"Science review: role of coagulation protease cascades in sepsis","volume":"7","author":"Riewald","year":"2003","journal-title":"Critical Care"},{"key":"10.1016\/j.bpa.2003.12.005_BIB85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-200301000-00002","article-title":"Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis","volume":"31","author":"Ely","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB86","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/01.CCM.0000051515.56179.E1","article-title":"Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial\u2217","volume":"31","author":"Vincent","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB87","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00134-003-1731-1","article-title":"Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial","volume":"29","author":"Dhainaut","year":"2003","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/cc2167","article-title":"Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis","volume":"7","author":"Bernard","year":"2003","journal-title":"Critical Care"},{"key":"10.1016\/j.bpa.2003.12.005_BIB89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00101-002-0436-0","article-title":"Klinisches Management bei Patienten mit Sepsis","volume":"52","author":"Weigand","year":"2003","journal-title":"Anaesthesist"},{"key":"10.1016\/j.bpa.2003.12.005_BIB90","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"High dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.bpa.2003.12.005_BIB91","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.145.11.3762","article-title":"Requirements of endogenous tumor necrosis factor\/cachectin for recovery from experimental peritonitis","volume":"145","author":"Echtenacher","year":"1990","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB92","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.173.4.1029","article-title":"A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice","volume":"173","author":"Alexander","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/314839","article-title":"Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock","volume":"180","author":"Cohen","year":"1999","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.bpa.2003.12.005_BIB94","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/00003246-199812000-00045","article-title":"Has the mortality of septic shock changed with time?","volume":"26","author":"Friedman","year":"1998","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bpa.2003.12.005_BIB96","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB97","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1084\/jem.188.12.2381","article-title":"A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection","volume":"188","author":"Boes","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB98","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB99","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/36586","article-title":"Impaired mast cell-dependent natural immunity in complement C3-deficient mice","volume":"390","author":"Prodeus","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35041591","article-title":"Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 [comment]","volume":"408","author":"Kleemann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s001090050204","article-title":"Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features","volume":"76","author":"Bernhagen","year":"1998","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB103","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00003246-200107001-00006","article-title":"Macrophage migration inhibitory factor and innate immune responses to bacterial infections","volume":"29","author":"Froidevaux","year":"2001","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1203\/00006450-200208000-00004","article-title":"High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid","volume":"52","author":"Zetterstr\u00f6m","year":"2002","journal-title":"Pediatric Research"},{"key":"10.1016\/j.bpa.2003.12.005_BIB105","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1164\/ajrccm.164.10.2106117","article-title":"HMGB1 as a late mediator of lethal systemic inflammation","volume":"164","author":"Wang","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.bpa.2003.12.005_BIB106","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB107","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/35074114","article-title":"TREM-1 amplifies inflammation and is a crucial mediator of septic shock","volume":"410","author":"Bouchon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB108","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V","article-title":"Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP\/DAP12-transgenic mice","volume":"32","author":"Lucas","year":"2002","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.12.005_BIB110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","article-title":"FADD\/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2","volume":"12","author":"Sprick","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bpa.2003.12.005_BIB111","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1093\/emboj\/cdf441","article-title":"Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8","volume":"21","author":"Sprick","year":"2002","journal-title":"EMBO Journal"},{"key":"10.1016\/j.bpa.2003.12.005_BIB112","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","article-title":"BH3-Only proteins\u2014essential initiators of apoptotic cell death","volume":"103","author":"Huang","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bpa.2003.12.005_BIB113","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.162.7.4148","article-title":"Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis","volume":"162","author":"Hotchkiss","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB114","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/82741","article-title":"Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte","volume":"1","author":"Hotchkiss","year":"2000","journal-title":"Nature Immunology"},{"key":"10.1016\/j.bpa.2003.12.005_BIB115","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.287.13.1716","article-title":"Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis","volume":"287","author":"Coopersmith","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.bpa.2003.12.005_BIB116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ni914","article-title":"Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2 [comment]","volume":"4","author":"Cauwels","year":"2003","journal-title":"Nature Immunology"}],"container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689603001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689603001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:26:48Z","timestamp":1776425208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689603001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1521689603001198"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2003.12.005","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The systemic inflammatory response syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2003.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}